Real-world experience of using basal insulin analogues in children with type 1 diabetes: is twice-daily dosing of insulin detemir justified?
Real-world experience of using basal insulin analogues in children with type 1 diabetes: is twice-daily dosing of insulin detemir justified?
Pediatr Endocrinol Diabetes Metab. 2019;25(2):103-105
Authors: Dayal D, Rohilla L
PMID: 31343144 [PubMed - in process]
Source: Pediatric Endocrinology, Diabetes, and Metabolism - Category: Endocrinology Authors: Dayal D, Rohilla L Tags: Pediatr Endocrinol Diabetes Metab Source Type: research